IPSS-R prognostic risk categories and clinical outcomes9
| Score . | Risk groups . | Median survival, y . | Median time to 25% AML evolution, y . |
|---|---|---|---|
| 0-1.5 | Very low risk | 8.8 | Not reached |
| 1.5-3 | Low | 5.3 | 10.8 |
| >3-4.5 | Intermediate | 3.0 | 3.2 |
| 4.5-6 | High | 1.6 | 1.4 |
| >6 | Very high | 0.8 | 0.73 |
| Score . | Risk groups . | Median survival, y . | Median time to 25% AML evolution, y . |
|---|---|---|---|
| 0-1.5 | Very low risk | 8.8 | Not reached |
| 1.5-3 | Low | 5.3 | 10.8 |
| >3-4.5 | Intermediate | 3.0 | 3.2 |
| 4.5-6 | High | 1.6 | 1.4 |
| >6 | Very high | 0.8 | 0.73 |